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Letter to the editor
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To the Editors,
We have read with interest the ar-
ticle by Occhipinti and Pastorelli, with 
particular reference to the manage-
ment of inflammatory bowel diseases 
(IBD) relapse during the COVID-19 
outbreak.1 Diagnostic challenges may 
arise in the presence of symptoms 
that overlap between active IBD and 
COVID-19, and concerns about the use 
of immunosuppressive drugs, mainly 
corticosteroids, which potentially lead 
to an increased risk for infections.2 
Lombardy, in northern Italy where our 
clinic is located, has been severely hit 
by COVID-19 since February 2020. We 
hereby report on a representative case 
of how COVID-19 has redefined prior-
ities and changed our clinical approach 
to active IBD patients.
In April 2020, a 29-year-old man 
with a 1-year history of ulcerative colitis 
(UC) on maintenance with mesalamine 
was admitted to our clinic with a 2-week 
history of fever up to 38.5°C, bloody 
diarrhea, dry cough, and ageusia. 
Physical examination revealed tachy-
cardia. Blood tests showed neutrophilia 
and increased C-reactive protein. 
Two consecutive nasopharyngeal plus 
one rectal swabs for SARS-CoV-2 
tested negative. A contrast-enhanced 
chest-abdomen-pelvis CT scan revealed 
no signs of pneumonia but a widely 
thickened and hyper-enhancing colonic 
wall (Fig. 1A). Abdominal imaging 
and gastrointestinal symptoms were 
consistent with IBD relapse. However, 
the persistence of fever, cough, and 
ageusia made it necessary to definitely 
rule COVID-19 out. After a multidis-
ciplinary discussion, a bronchoalveolar 
lavage was performed, which eventu-
ally tested negative for SARS-CoV-2. 
Ileocolonoscopy, performed 2 days later, 
showed segmental cobblestone appear-
ance and scattered aphthous erosions in 
the right and left colon (Fig. 1B), as op-
posed to a relative sparing of the rectum 
(Fig. 1C). Histological examination was 
consistent with IBD colitis. A diagnosis 
of severe flare of IBD-unclassified was 
made, and corticosteroid therapy was 
initiated, with the subsequent rapid im-
provement of both gastrointestinal and 
respiratory symptoms.
Gastrointestinal manifestations 
have occurred in about half of COVID-
19 patients and may precede respiratory 
symptoms.3 Therefore, the differen-
tial diagnosis between IBD relapse and 
SARS-CoV-2 infection has possibly 
proved challenging at the peak of the 
COVID-19 outbreak. Currently, ruling 
out COVD-19 has become a priority for 
both clinical and public health reasons, 
and the timing of endoscopic exami-
nation, as well as treatment decisions, 
closely depend on the COVID-19 di-
agnostic results.4 Ageusia and anosmia 
have been reported in about one third of 
COVID-19 patients,5 whereas they have 
rarely been observed in IBD patients. 
Ageusia, as reported by our patient, 
contributed to increase the suspicion of 
SARS-CoV-2 infection and made the 
differential diagnosis trickier.
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FIGURE 1. A, CT scan image showing a cross-sectioned descending colon (white arrow) with wall thickening and mucosal hyperenhancement. B, 
Left-colon image showing mucosal oedema, cobblestone appearance, and aphthous erosions. C, Rectum image showing an endoscopically normal 
appearance of the mucosa.
D
ow
nloaded from
 https://academ
ic.oup.com
/ibdjournal/advance-article/doi/10.1093/ibd/izaa184/5877398 by U
niverità degli Studi di M
ilano user on 17 August 2020
